CRISPR gene editing is a breakthrough that has been used to treat diseases such as sickle cell anemia, leukemia and genetic disorders, but it has challenges that limit its broad utility. Let’s take a look.
Read More
A relatively new method of heart transplantation, which allows for the use of hearts donated after circulatory death could expand the pool of available donor hearts by a projected 30%. Here’s what’s happening.
Read More
As the COVID-19 pandemic officially ends today, Dr. Cameron Wolfe, an infectious disease specialist who served on the front lines of care at Duke, reflects on all that has transpired over the past three years.
Read More
Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to transform healthcare by making biomedical knowledge computable.
Read More
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.
Read More
A 17-day-old newborn recently had a first-of-its kind surgery at Duke Health to repair a heart defect.
Read More
About one in seven breast cancers detected by mammography screening are over-diagnosed, according to a Duke Cancer Institute study designed to clarify the risk of breast cancer over-diagnosis using contemporary screening technology in the U.S.
Read More
A research team led by the Duke Cancer Institute describe how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.
Read More
A study led by the Duke Clinical Research Institute has expanded its testing platform to evaluate three repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.
Read More
